Foghorn Therapeutics Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Foghorn Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Foghorn Therapeutics Inc. Operating Margin for the quarter ending September 30, 2024 was -408 %, a 16.3% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Operating Margin for 2023 was -316 %, a 48.1% increase from 2022.
  • Foghorn Therapeutics Inc. annual Operating Margin for 2022 was -609 %, a 92% increase from 2021.
  • Foghorn Therapeutics Inc. annual Operating Margin for 2021 was -7.64K %, a 52.1% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -408 -57.1 -16.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -277 +301 +52.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -303 +292 +49% Jan 1, 2024 Mar 31, 2024
Q4 2023 -316 +293 +48.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -351 +368 +51.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -578 +637 +52.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -595 +1.53K +72% Jan 1, 2023 Mar 31, 2023
Q4 2022 -609 +7.03K +92% Oct 1, 2022 Dec 31, 2022
Q3 2022 -719 +10.2K +93.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.21K +7.39K +85.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.13K +8.76K +80.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.64K +8.3K +52.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -10.9K Jul 1, 2021 Sep 30, 2021
Q2 2021 -8.61K Apr 1, 2021 Jun 30, 2021
Q1 2021 -10.9K Jan 1, 2021 Mar 31, 2021
Q4 2020 -15.9K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.